Arkema S.A. (OTCMKTS:ARKAY) Short Interest Down 21.7% in October

Arkema S.A. (OTCMKTS:ARKAY) was the target of a significant drop in short interest in October. As of October 31st, there was short interest totalling 1,800 shares, a drop of 21.7% from the October 15th total of 2,300 shares. Based on an average daily volume of 15,300 shares, the days-to-cover ratio is currently 0.1 days.

Analyst Ratings Changes

Separately, Berenberg Bank upgraded shares of Arkema from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 31st.

Arkema Stock Performance

Shares of OTCMKTS ARKAY opened at $82.27 on Friday. The stock’s 50-day moving average is $89.96 and its 200 day moving average is $92.87. The stock has a market cap of $6.26 billion, a price-to-earnings ratio of 16.44, a P/E/G ratio of 0.39 and a beta of 1.27. Arkema has a 1-year low of $79.57 and a 1-year high of $114.15. The company has a current ratio of 1.86, a quick ratio of 1.38 and a debt-to-equity ratio of 0.38.

Arkema (OTCMKTS:ARKAY) last posted its quarterly earnings results on Wednesday, November 6th. The basic materials company reported $2.45 EPS for the quarter. Arkema had a net margin of 3.82% and a return on equity of 7.99%. The firm had revenue of $2.63 billion for the quarter. On average, sell-side analysts anticipate that Arkema will post 8.89 EPS for the current fiscal year.

About Arkema

Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.